Essential Tremor Resources for Healthcare Providers
The International Essential Tremor Foundation (IETF) depends on healthcare providers and physicians who specialize in essential tremor to help those affected better understand their condition. By partnering with the IETF, we can provide your patients with a wealth of quality information and support … all at no cost to you.
IETF ET RESEARCH GRANTS
James Parkinson first distinguished essential tremor from other tremor disorders (including the disease that carries his namesake) in 1817. More than 200 years later, there are still many unanswered questions about essential tremor. However, researchers are moving our knowledge forward. It is vital to understand what causes ET in order to develop tailored treatment options and a cure for this life-altering condition. Learn more about essential tremor research grants.
The Brain and Body Donation Program (BBDP) is an autopsy-based, research-devoted brain bank, biobank and biospecimen bank that derives its human donors from the Arizona Study of Aging and Neurodegenerative Disease (AZSAND), a longitudinal clinicopathological study of the health and diseases of elderly volunteers living in Maricopa county and metropolitan Phoenix, Arizona. The BBDP studies their function during life and their organs and tissue after death. To date, they have concentrated their studies on Alzheimer’s disease, Parkinson’s disease, heart disease and cancer. They have also banked brain tissue from 76 subjects diagnosed with essential tremor during life. They share their banked tissue, biomaterials and biospecimens with qualified researchers worldwide.
Authors: Robert Fekete and Jin Li
Publication Date: 29 Apr 2013
Type: Case report Journal: Clinical Medicine Insights: Case Reports
Citation: Clinical Medicine Insights: Case Reports 2013:6 67-74
Oct 2011 – Updated Guideline on Essential Tremor Published by AAN
An updated evidence-based guideline published by the AAN shows that certain drugs can help improve tremor in people with essential tremor (ET), but not all people with the disorder will be able to tolerate the drugs or find improvement in their symptoms. The guideline was published online ahead of print on October 19, 2011, and in print in the November 8, 2011, issue of Neurology®.